- Home
- PHVS vs NBHC Comparison
PHVS vs NBHC Comparison
Compare PHVS & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- NBHC
- Stock Information
- Founded
- PHVS 2015
- NBHC 2009
- Country
- PHVS Switzerland
- NBHC United States
- Employees
- PHVS N/A
- NBHC N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- NBHC Major Banks
- Sector
- PHVS Health Care
- NBHC Finance
- Exchange
- PHVS Nasdaq
- NBHC Nasdaq
- Market Cap
- PHVS 1.6B
- NBHC 1.4B
- IPO Year
- PHVS 2021
- NBHC 2012
- Fundamental
- Price
- PHVS $22.46
- NBHC $35.82
- Analyst Decision
- PHVS Buy
- NBHC Buy
- Analyst Count
- PHVS 6
- NBHC 3
- Target Price
- PHVS $36.50
- NBHC $44.33
- AVG Volume (30 Days)
- PHVS 217.3K
- NBHC 321.4K
- Earning Date
- PHVS 11-12-2025
- NBHC 10-21-2025
- Dividend Yield
- PHVS N/A
- NBHC 3.51%
- EPS Growth
- PHVS N/A
- NBHC N/A
- EPS
- PHVS N/A
- NBHC 3.15
- Revenue
- PHVS N/A
- NBHC $405,867,000.00
- Revenue This Year
- PHVS N/A
- NBHC $8.33
- Revenue Next Year
- PHVS N/A
- NBHC $23.76
- P/E Ratio
- PHVS N/A
- NBHC $11.23
- Revenue Growth
- PHVS N/A
- NBHC 1.03
- 52 Week Low
- PHVS $11.51
- NBHC $32.83
- 52 Week High
- PHVS $26.33
- NBHC $51.76
- Technical
- Relative Strength Index (RSI)
- PHVS 47.79
- NBHC 39.75
- Support Level
- PHVS $21.99
- NBHC $35.56
- Resistance Level
- PHVS $23.64
- NBHC $37.83
- Average True Range (ATR)
- PHVS 1.28
- NBHC 0.98
- MACD
- PHVS -0.01
- NBHC -0.11
- Stochastic Oscillator
- PHVS 52.17
- NBHC 22.55
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About NBHC National Bank Holdings Corporation
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.